A Novel Method to Generate Analyte-Specific Specimens for Multi-Omic Studies of Primary Bladder Cancer

Area of Science:

• Biotechnology
• Cancer Research
• Biobanking

Background:

• Clinical tumor tissue is crucial for emerging omic technologies but often processed via formalin-fixation and paraffin-embedding, limiting its use.
• A novel approach was developed to overcome these limitations, offering biobanks a way to generate unique specimens for omic studies.

Purpose of the Study:

• To demonstrate a new specimen processing method for creating dedicated multi-omic study samples from clinical tissues.
• To ensure the method does not detract from standard formalin-fixed, paraffin-embedded processing.

Main Methods:

• Aliquots for exosome and metabolite studies were generated from primary bladder cancers.
• Tumor-derived exosomes were analyzed using a biosensor, and metabolites were profiled via liquid-chromatography tandem mass spectrometry.
• Intact cells were recovered for cytological examination to confirm tumor cell phenotype.

Main Results:

• Recovered diagnostic tumor cells were morphologically consistent with original tissue.
• Tumor-specific signal molecules were confirmed in isolated exosomes.
• Identifiable metabolites from multiple classes were extracted and detected in dedicated aliquots.

Conclusions:

• The developed tumor specimen processing approach provides biobanks with a novel method to generate dedicated aliquots for cancer research.
• This method supports the study of under-investigated cancer analytes, crucial for understanding cancer complexity.
• Adoption of this technique can advance research into critical cancer biomarkers.